G Medical Engages US Underwriter to Manage Dual-Listing on NASDAQ
October 02 2018 - 12:08PM
Business Wire
Underwriter engaged for the purposes of US
Public Offering with intention of dual listing
Mobile and e-Health company G Medical Innovations (ASX: GMV) (“G
Medical” or the “Company”) has today engaged a New York based
Underwriter, to assist in the processes towards a US Public
Offering via the NASDAQ Stock Exchange.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20181002005846/en/
G Medical Innovations Structure (Graphic:
Business Wire)
The Company will remain listed on the Australian Stock Exchange,
and the management of G Medical have engaged an Underwriter who
will now proceed with submission of the F-1 Registration Statement
with all parties working towards a US listing within the next 4 to
5 months.
G Medical cautions investors that there can be no certainty that
the proposed US listing will proceed. Investors should note that
the listing is subject to satisfaction of all legal and regulatory
requirements with NASDAQ, SEC and ASX, as well as any shareholder
approvals that may be required under the ASX Listing Rules.
Shareholders will be updated throughout the process as
appropriate, and the amount of capital to be raised will be
determined closer to the proposed offering.
About G Medical
Innovations
G Medical (ASX: GMV) was founded in August 2014, aiming to be at
the forefront of the digital health revolution, developing the next
generation of mobile health (mHealth) technologies. The Company
leverages the experience and expertise of its Board to deliver
best-in-class solutions to address this global opportunity.
The Company specialises in innovative next generation mobile and
e-health solutions and services using its suite of devices and
software solutions with a view to driving multiple and recurring
revenue streams, across numerous verticals and territories.
For more information on G Medical, please
visit www.gmedinnovations.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181002005846/en/
Corporate AdvisorsOtsana Capital108 Outram
StreetWest Perth WA 6005Telephone: +61 8 9486
7244www.otsana.comorInvestor RelationsViriathus
AustraliaLevel 8/525 Flinders StreetMelbourne VIC
3000Telephone: +61 2 8667 5360www.viriathus.comorMedia
EnquiriesCloser CommunicationsDavid WolfTelephone: + 61
411 111 787david@closer.com.au
G Medical Innovations (ASX:GMV)
Historical Stock Chart
From Dec 2024 to Jan 2025
G Medical Innovations (ASX:GMV)
Historical Stock Chart
From Jan 2024 to Jan 2025